Denali Therapeutics Inc
Ownership
Ownership Structure
Who owns Denali Therapeutics Inc (DNLI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.0% of the shares are freely tradable; institutional investors hold 99.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.15 | 13,034,434 | +2.5 | 03/31/2026 |
| Baillie Gifford & Co Limited. | 7.48 | 11,960,230 | -0.9 | 06/30/2026 |
| T. Rowe Price Investment Management,Inc. | 5.33 | 8,519,192 | +0.2 | 03/31/2026 |
| Temasek Holdings Ltd. | 4.39 | 7,012,974 | +0.0 | 06/30/2026 |
| State Street Corp | 3.92 | 6,272,001 | +0.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.85 | 6,147,957 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.83 | 6,120,160 | +0.0 | 03/31/2026 |
| FMR Inc | 2.86 | 4,575,374 | -25.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Scottish Mortgage Ord | 4.41 | 7,041,270 | +0.0 | 07/31/2026 |
| T. Rowe Price Capital Appreciation | 3.87 | 6,186,533 | +24.6 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Watts Ryan J. | President and CEO | 2,120,384 | 41,771,565 $ | Aug 12, 2026 | indirect |
| Schuth Alexander O. | COFO and Secretary | 278,995 | 5,496,202 $ | Sep 1, 2026 | direct |
| Chin Peter Scott | Chief Medical Officer | 204,538 | 4,029,399 $ | Sep 4, 2026 | direct |
| Thornberry Nancy | Director | 19,686 | 387,814 $ | Sep 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Chin Peter Scott | Chief Medical Officer | Sell | 1,654 | 22.29 | 36,868 |
| Sep 2, 2026 | Thornberry Nancy | Director | Sell | 615 | 23.74 | 14,600 |
| Sep 2, 2026 | Thornberry Nancy | Director | Sell | 10,824 | 22.85 | 247,328 |
| Sep 1, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | 2,768 | 23.44 | 64,882 |
| Aug 12, 2026 | Watts Ryan J. | President and CEO | Other | 32,220 | 0.00 | – |
| Aug 11, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | 2,857 | 25.07 | 71,625 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.